Cleared Traditional

K212326 - AC Cream - Conductive paste

K212326 is an FDA 510(k) clearance for AC Cream - Conductive paste, manufactured by Spes Medica Srl. The device is a Class 2 Neurology device with product code GYB cleared through the Traditional 510(k) pathway after a 128-day FDA review.

K212326 · Spes Medica Srl · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
128d
Days
Class 2
Risk

K212326 is an FDA 510(k) clearance for the AC Cream - Conductive paste. Classified as Media, Electroconductive (product code GYB), Class II - Special Controls.

Submitted by Spes Medica Srl (Battipaglia, IT). The FDA issued a Cleared decision on December 1, 2021 after a review of 128 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1275 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Spes Medica Srl devices

FDA 510(k) Submission Details - K212326

510(k) Number K212326 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2021
Decision Date December 01, 2021
Days to Decision 128 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 148d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GYB Device Classification - Class 2, Special Controls

Product Code GYB Media, Electroconductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1275
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GYB Media, Electroconductive

All 28
Devices cleared under the same product code (GYB) and FDA review panel - the closest regulatory comparables to K212326.
Conductive Gel
K222770 · Top-Rank Health Care Co., Ltd. · Dec 2022
Conductive Gel
K221724 · Tone-A-Matic International, Inc. · Sep 2022
EEG-acp
K212325 · Somnomedics GmbH · Jun 2022
GT5 conductive & abrasive gel
K212787 · Wuhan Greentek Pty , Ltd. · Nov 2021
DR-HO'S Electro Therapy Conductive Gel
K200402 · Guangzhou Xinbo Electronic Co., Ltd. · Nov 2020
Elefix V Paste for EEG & EMG
K191975 · Nihon Kohden Corporation · Feb 2020